While a wide range of pharmacological treatments and disease management regimens exist to treat these conditions with varying degrees of efficacy, a promising new drug class known as glucagon-like peptide 1 receptor agonists (GLP-1s) and combination incretins such as dual GLP-1/glucosedependent insulinotropic polypeptides (GLP-1/GIPs, a subcategory of GLP-1s) has attracted widespread attention and interest from providers and patients for its potential to treat both these and adjacent conditions, and especially to drive weight loss
It can also be used for patients with established cardiovascular disease to reduce the risk of major cardiovascular events
GLP-1 acts on the satiety-hunger center in the brain located in the hypothalamus to lessen the urge to eat more food
Tirzepatide significantly reduced the number of breathing interruptions during sleep a key measure of disease severity for clinically obese people living with moderate-to-severe obstructive sleep apnea, according to the results of two clinical trials published in the New England Journal of Medicine
Choose nutrient-dense foods Examples include: Eggs Fish or chicken Beans and lentils Whole grains Fruits and vegetables Nuts and seeds Healthy fats Stay hydrated Aim for 23 liters of fluid per day , especially if experiencing nausea or digestive side effects
(2023) The supply and use of Ozempic